Affimed Therapeutics B V shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Affimed Therapeutics B V
Tip: Access up to 7 years of quarterly data
All positions including Affimed Therapeutics B V held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Affimed Therapeutics B V by Goldman Sachs Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $17k | 27k | 0.63 |
2023-09-30 | $27k | 56k | 0.48 |
2023-06-30 | $184k | 308k | 0.60 |
2023-03-31 | $194k | 260k | 0.75 |
2022-12-31 | $1.1M | 916k | 1.24 |
2022-06-30 | $1.6M | 562k | 2.77 |
2022-03-31 | $4.6M | 1.1M | 4.37 |
2021-12-31 | $8.7M | 1.6M | 5.52 |
2021-09-30 | $18M | 2.8M | 6.18 |
2021-03-31 | $18M | 2.3M | 7.91 |
2020-12-31 | $11M | 1.9M | 5.82 |
2020-09-30 | $924k | 272k | 3.39 |
2020-06-30 | $1.4M | 305k | 4.62 |
2019-12-31 | $994k | 363k | 2.74 |
2019-09-30 | $2.0M | 680k | 2.94 |
2019-06-30 | $327k | 114k | 2.87 |
2019-03-31 | $68k | 16k | 4.22 |
2018-09-30 | $111k | 26k | 4.35 |
2018-06-30 | $36k | 22k | 1.67 |
2018-03-31 | $20k | 11k | 1.81 |
2017-12-31 | $14k | 11k | 1.27 |
2017-09-30 | $67k | 30k | 2.24 |
2017-06-30 | $81k | 39k | 2.06 |
2017-03-31 | $104k | 45k | 2.30 |
2016-12-31 | $173k | 96k | 1.80 |
2016-09-30 | $149k | 54k | 2.77 |
2016-06-30 | $155k | 62k | 2.48 |
2016-03-31 | $59k | 16k | 3.72 |
2015-12-31 | $223k | 31k | 7.13 |
2015-09-30 | $69k | 11k | 6.17 |